Atul Malhotra, MD, PhD, on the Importance of Preclinical Work for Bringing Cell Therapies to Clinic
The head of the early neurodevelopment clinic at Monash Children's Hospital discussed preclinical work in the context of neonatal cell therapy research.
“Neonatology as a profession has been trying to improve the care of these [preterm] infants so they have less complications down the line. We are doing better in some aspects, but still continue to have a significant burden of disease when it comes to lung and brain complications. Cell therapy is an opportunity for us to improve those outcomes further. [We], and a number of groups around the world, have been trying to discover and then translate these cell therapies into human babies.”
In October 2022, Atul Malhotra, MD, PhD, the head of the early neurodevelopment clinic at Monash Children's Hospital,
With well over a year having passed since the publication of the original article, CGTLive reached out to Malhotra to check in on the current state of the group’s work and to get his perspective on the role of their research. In the interview, Malhotra first discussed the difference between stem cells and cell therapy in general. Afterwards, he spoke about unmet needs in the treatment of complications related to premature births and how cell therapy may help to address these unmet needs. Malhotra emphasized that since the publication of his article in 2022, substantial activity and advancements have continued to take place on both the preclinical and clinical sides of research in this field. He then summarized major considerations for the preclinical side as they relate to pushing the field forward.
REFERENCE
1. Lions Foundation provides support to neonatal cell therapy research. News release. Monash Unviersity. August 25, 2022. https://www.monash.edu/medicine/news/latest/2022-articles/lions-foundation-provides-support-to-neonatal-cell-therapy-research
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Related Articles
- Around the Helix: Cell and Gene Therapy Company Updates – September 17, 2025
September 17th 2025
- ImmunoLogic, Episode 6: "The Future of Personalized Cancer Vaccines”
September 15th 2025
- Top News in Lymphoma Cell Therapy for World Lymphoma Awareness Day 2025
September 15th 2025